Survey of Ophthalmology
Volume 50, Issue 1 , Pages 48-60 , January 2005

Glaucoma drainage devices: a systematic literature review and current controversies

  • Chian-Huey Hong, MD

      Affiliations

    • Department of Ophthalmology, Tulane School of Medicine, Tulane University, New Orleans, Louisiana
    • ,
  • Analisa Arosemena, MD

      Affiliations

    • Department of Ophthalmology, Tulane School of Medicine, Tulane University, New Orleans, Louisiana
    • ,
  • David Zurakowski, PhD

      Affiliations

    • Department of Biostatistics, Children's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Ramesh S. Ayyala, MD, FRCS, FRCOphth

      Affiliations

    • Department of Ophthalmology, Tulane School of Medicine, Tulane University, New Orleans, Louisiana

References 

  1. —: Krupin eye valve with disk for filtration surgery. The Krupin Eye Valve Filtering Surgery Study Group. Ophthalmology. 1994;101:651–658
  2. Airaksinen PJ, Aisala P, Tuulonen A. Molteno implant surgery in uncontrolled glaucoma. Acta Ophthalmol (Copenh). 1990;68:690–694
  3. Aung T, Seah SK. Glaucoma drainage implants in Asian eyes. Ophthalmology. 1998;105:2117–2122
  4. Ayyala RS, Harman LE, Michelini-Norris B, et al. Comparison of different biomaterials for glaucoma drainage devices. Arch Ophthalmol. 1999;117:233–236
  5. Ayyala RS, Layden WE, Slonim CB, et al. Anatomic and histopathologic findings following a failed ahmed glaucoma valve device. Ophthalmic Surg Lasers. 2001;32:248–249
  6. Ayyala RS, Michelini-Norris B, Flores A, et al. Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol. 2000;118:1081–1084
  7. Ayyala RS, Parma SE, Karcioglu ZA. Optic nerve changes following posterior insertion of glaucoma drainage device in rabbit model. J Glaucoma. 2004;13:145–148
  8. Ayyala RS, Pieroth L, Vinals AF, et al. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium: YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. Ophthalmology. 1998;105:1550–1556
  9. Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33:94–101
  10. Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976
  11. Beebe WE, Starita RJ, Fellman RL, et al. The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients. Ophthalmology. 1990;97:1414–1422
  12. Bigar F, Witmer R. Corneal endothelial changes in primary acute angle-closure glaucoma. Ophthalmology. 1982;89:596–599
  13. Bluestein EC, Stewart WC. Trabeculectomy with 5-fluorouracil vs single-plate Molteno implantation. Ophthalmic Surg. 1993;24:669–673
  14. Bock RH. Subconjunctival drainage of the anterior chamber by a glass seton. Am J Ophthalmol. 1950;33:929
  15. Britt MT, LaBree LD, Lloyd MA, et al. Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better?. Ophthalmology. 1999;106:2312–2318
  16. Broadway DC, Iester M, Schulzer M, et al. Survival analysis for success of Molteno tube implants. Br J Ophthalmol. 2001;85:689–695
  17. Brown RD, Cairns JE. Experience with the Molteno long tube implant. Trans Ophthalmol Soc UK. 1983;103:297–312
  18. Cantor L, Burgoyne J, Sanders S, et al. The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma. 1998;7:240–246
  19. Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1995;120:23–31
  20. Downes RN, Flanagan DW, Jordan K, et al. The Molteno implant in intractable glaucoma. Eye. 1988;2(Pt 3):250–259
  21. Egbert PR, Lieberman MF. Internal suture occlusion of the Molteno glaucoma implant for the prevention of postoperative hypotony. Ophthalmic Surg. 1989;20:53–56
  22. In:  Egger M,  Smith GD,  Altman DG editor. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Publishing Group; 2001;p. 23–68
  23. el-Sayyad F, el-Maghraby A, Helal M, et al. The use of releasable sutures in Molteno glaucoma implant procedures to reduce postoperative hypotony. Ophthal Surg. 1991;22:82–84
  24. Epstein E. Fibrosis response to aqueous. Its relationship to glaucoma. Br J Ophthalmol. 1959;43:641–647
  25. Fellenbaum PS, Almeida AR, Minckler DS, et al. Krupin disk implantation for complicated glaucomas. Ophthalmology. 1994;101:1178–1182
  26. Fleiss JL. The comparison of proportions from several independent samples in Statistical methods for rates and proportions. ed 2. New York: John Wiley & Sons; 1981;pp 138–59
  27. Freedman J. Clinical experience with the Molteno dual-chamber single-plate implant. Ophthal Surg. 1992;23:238–241
  28. Freedman J. The use of the single stage Molteno long tube seton in treating resistant cases of glaucoma. Ophthalmic Surg. 1985;16:480–483
  29. Freedman J, Rubin B. Molteno implants as a treatment for refractory glaucoma in black patients. Arch Ophthalmol. 1991;109:1417–1420
  30. Goldberg I. Management of uncontrolled glaucoma with the Molteno system. Aust NZ J Ophthalmol. 1987;15:97–107
  31. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology. 1992;99:1512–1519
  32. Hill RA, Pirouzian A, Liaw L. Pathophysiology of and prophylaxis against late ahmed glaucoma valve occlusion. Am J Ophthalmol. 2000;129:608–612
  33. Hoare Nairne JE, Sherwood D, Jacob JS, et al. Single stage insertion of the Molteno tube for glaucoma and modifications to reduce postoperative hypotony. Br J Ophthalmol. 1988;72:846–851
  34. Hodkin MJ, Goldblatt WS, Burgoyne CF, et al. Early clinical experience with the Baerveldt implant in complicated glaucomas. Am J Ophthalmol. 1995;120:32–40
  35. Huang MC, Netland PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;127:27–33
  36. Joos KM, Laviña AM, Tawansy KA, et al. Posterior repositioning of glaucoma implants for anterior segment complications. Ophthalmology. 2001;108:279–284
  37. Kee C. Prevention of early postoperative hypotony by partial ligation of silicone tube in Ahmed glaucoma valve implantation. J Glaucoma. 2001;10:466–469
  38. Kirkness CM. Penetrating keratoplasty, glaucoma and silicone drainage tubing. Dev Ophthalmol. 1987;14:161–165
  39. Kook MS, Yoon J, Kim J, et al. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C. Ophthalmic Surg Lasers. 2000;31:100–106
  40. Krishna R, Godfrey DG, Budenz DL, et al. Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants. Ophthalmology. 2001;108:621–626
  41. Krupin T, Podos SM, Becker B, et al. Valve implants in filtering surgery. Am J Ophthalmol. 1976;81:232–235
  42. Lai JS, Poon AS, Chua JK, et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol. 2000;84:718–721
  43. Latina MA. Single stage Molteno implant with combination internal occlusion and external ligature. Ophthalmic Surg. 1990;21:444–446
  44. Lee D, Shin DH, Birt CM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1997;104:2126–2135
  45. Leen MM, Witkop GS, George DP. Anatomic considerations in the implantation of the Ahmed glaucoma valve. Arch Ophthalmol. 1996;114:223–224
  46. Lloyd MA, Baerveldt G, Fellenbaum PS, et al. Intermediate-term results of a randomized clinical trial of the 350- versus the 500-mm2 Baerveldt implant. Ophthalmology. 1994;101:1456–1463discussion 1463–4
  47. Lloyd MA, Baerveldt G, Heuer DK, et al. Initial clinical experience with the baerveldt implant in complicated glaucomas. Ophthalmology. 1994;101:640–650
  48. Lloyd MA, Heuer DK, Baerveldt G, et al. Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas. Ophthalmology. 1991;98:1401–1405
  49. Lloyd MA, Sedlak T, Heuer DK, et al. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Update of a pilot study. Ophthalmology. 1992;99:679–687
  50. Lotufo DG. Postoperative complications and visual loss following Molteno implantation. Ophthalmic Surg. 1991;22:650–656
  51. McDermott ML, Swendris RP, Shin DH, et al. Corneal endothelial cell counts after Molteno implantation. Am J Ophthalmol. 1993;115:93–96
  52. Melamed S, Cahane M, Gutman I, et al. Postoperative complications after Molteno implant surgery. Am J Ophthalmol. 1991;111:319–322
  53. Mermoud A, Salmon JF, Straker C, et al. Use of the single-plate Molteno implant in refractory glaucoma. Ophthalmologica. 1992;205:113–120
  54. Mills RP, Reynolds A, Emond MJ, et al. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103:299–305
  55. Minckler DS, Heuer DK, Hasty B, et al. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Ophthalmology. 1988;95:1181–1188
  56. Minckler DS, Shammas A, Wilcox M, et al. Experimental studies of aqueous filtration using the Molteno implant. Trans Am Ophthalmol Soc. 1987;85:368–392
  57. Molteno AC, Bevin TH, Herbison P, et al. Otago glaucoma surgery outcome study: long-term follow-up of cases of primary glaucoma with additional risk factors drained by Molteno implants. Ophthalmology. 2001;108:2193–2200
  58. Molteno AC, Polkinghorne PJ, Bowbyes JA. The vicryl tie technique for inserting a draining implant in the treatment of secondary glaucoma. Aust NZ J Ophthalmol. 1986;14:343–354
  59. Molteno AC, Straughan JL, Ancker E, et al. Long tube implants in the management of glaucoma. S Afr Med J. 1976;50:1062–1066
  60. Molteno ACB. The optimal design of drainage implants for glaucoma. Trans Ophthalmol Soc NZ. 1981;33:29–41
  61. Molteno ACB. New implant for draining in glaucoma. Br J Ophthalmol. 1969;53:609
  62. Molteno ACB, Dempster AG. Methods of controlling bleb fibrosis around draining implants. In:  Mills KB editors. Glaucoma: Proceedings of Fourth International Symposium of the North Eye Institute. Manchester/Elmsford: Pergamon Press Inc; 1988;p. 192–211
  63. Molteno ACB, Dempster AG. Methods of controlling bleb fibrosis around draining implants. In:  Mills KB editors. Glaucoma: Proceedings of Fourth International Symposium of the North Eye Institute. Manchester, UK; Elmsford, NY: Pergamon Press Inc; 1988;p. 192–211
  64. Molteno ACB, Fucik M, Dempster AG, Bevin TH. Otago glaucoma surgery outcome study: factors controlling capsule fibrosis around Molteno implants with histological correlation. Ophthalmology. 2003;110:2198–2206
  65. Molteno ACB, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J. 1976;50:881–885
  66. Muldoon WE, Ripple PH, Wilder HC. Platinum implant in glaucoma surgery. Arch Ophthalmol. 1951;45:666
  67. Neelakantan A, Rao BS, Vijaya L, et al. Single-plate Molteno implants in complicated glaucomas: results, survival rates, and complications. Indian J Ophthalmol. 1994;42:193–197
  68. Nguyen QH, Budenz DL, Parrish RK. Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol. 1998;116:571–575
  69. Perkins TW, Cardakli UF, Eisele JR, et al. Adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1995;102:91–97
  70. Perkins TW, Gangnon R, Ladd W, et al. Molteno implant with mitomycin C: intermediate-term results. J Glaucoma. 1998;7:86–92
  71. Petitti DB. Advanced issues in Meta-Analysis, decision analysis, and cost-effective analysis: methods for quantitative synthesis in medicine. ed 2. New York: Oxford University Press; 2000;pp 75–93
  72. Piantadosi S. Overviews/Meta-Analyses in Clinical Trials: A Methodologic Perspective. New York: John Wiley & Sons; 1997;pp 419–31
  73. Price FW, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg. 1995;26:130–135
  74. Price FW, Whitson WE. Polypropylene ligatures as a means of controlling intraocular pressure with Molteno implants. Ophthalmic Surg. 1989;20:781–783
  75. Rapuano CJ, Schmidt CM, Cohen EJ, et al. Results of alloplastic tube shunt procedures before, during, or after penetrating keratoplasty. Cornea. 1995;14:26–32
  76. Rollet M. Le drainage au irin de la chambre anterieure contre l'hypertonie et al douleur. Rev Gen Ophthalmol. 1906;25:481
  77. Schocket SS. Investigations of the reasons for success and failure in the anterior shunt-to-the-encircling-band procedure in the treatment of refractory glaucoma. Trans Am Ophthalmol Soc. 1986;84:743–798
  78. Sherwood MB, Smith MF. Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology. 1993;100:85–90
  79. Sidoti PA, Mosny AY, Ritterband DC, et al. Pars plana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal disease. Ophthalmology. 2001;108:1050–1058
  80. Siegner SW, Netland PA, Urban RC, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology. 1995;102:1298–1307
  81. Smith MF, Doyle JW, Sherwood MB. Comparison of the Baerveldt glaucoma implant with the double-plate Molteno drainage implant. Arch Ophthalmol. 1995;113:444–447
  82. Smith MF, Sherwood MB, McGorray SP. Comparison of the double-plate Molteno drainage implant with the Schocket procedure. Arch Ophthalmol. 1992;110:1246–1250
  83. Smith SL, Starita RJ, Fellman RL, et al. Early clinical experience with the Baerveldt 350-mm2 glaucoma implant and associated extraocular muscle imbalance. Ophthalmology. 1993;100:914–918
  84. Stefansson J. An operation for glaucoma. Am J Ophthalmol. 1925;8:681–692
  85. Stewart WC, Connor AB, Pitts RA. Prognostic factors and postoperative course following single-plate Molteno implantation. Doc Ophthalmol. 1994;86:409–417
  86. Susanna R, Nicolela MT, Takahashi WY. Mitomycin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg. 1994;25:458–462
  87. Svedberg B. Effects of artificial intraocular pressure elevation on the corneal endothelium in the vervet monkey. Acta Ophthalmol. 1973;53:839–855
  88. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178:2147–2156
  89. Teng CC, Chi HH, Katzin HM. Histology and mechanism of filtering operations. Am J Ophthalmol. 1959;47:16–34
  90. Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;128:198–204
  91. Traverso CE, Tomey KF, al-Kaff A. The long-tube single plate Molteno implant for the treatment of recalcitrant glaucoma. Int Ophthalmol. 1989;13:159–162
  92. Tronsco MU. Use of tantalum implants for inducing a permanent hypotony in rabbit eyes. Am J Ophthalmol. 1949;32:499–508
  93. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma—A single surgeon comparison of outcome. Ophthalmology. 2003;110:1814–1821
  94. Varma R, Heuer DK, Lundy DC, et al. Pars plana Baerveldt tube insertion with vitrectomy in glaucomas associated with pseudophakia and aphakia. Am J Ophthalmol. 1995;119:401–407
  95. Verdonck C, Van de Velde T, Zeyen T. Clinical experience with the single-plate Molteno drainage implant. Bull Soc Belge Ophtalmol. 1995;255:27–32
  96. Ward WJ, Cooper RL. Molteno tube implants: long-term results. Aust NZ J Ophthalmol. 1987;15:109–112
  97. Wilcox MJ, Barad JP, Wilcox CC, et al. Performance of a new, low-volume, high-surface area aqueous shunt in normal rabbit eyes. J Glaucoma. 2000;9:74–82
  98. Wilson MR, Mendis U, Smith SD, et al. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol. 2000;130:267–273
  99. Wilson RP, Cantor L, Katz LJ, et al. Aqueous shunts. Molteno versus Schocket. Ophthalmology. 1992;99:672–676discussion 676–8
  100. Zorab A. The reduction of tension in chronic glaucoma. Ophthalmoscope. 1912;10:258

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Presented as a poster at the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 2001, and supported, in part, by the Tulane Glaucoma Research Fund.No reprints will be available from the authors.

PII: S0039-6257(04)00161-4

doi: 10.1016/j.survophthal.2004.10.006

Survey of Ophthalmology
Volume 50, Issue 1 , Pages 48-60 , January 2005

Article Tools